Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Live Attenuated Herpes Zoster Vaccine in Chinese Adults
NCT02526745Phase 2Completed
- Sponsor
- Beijing Chaoyang District Center for Disease Control and Prevention
- Start
- Dec 2015
- Primary completion
- Jul 2016
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 2 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by Beijing Chaoyang District Center for Disease Control and Prevention. Started Dec 2015; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02526745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526745.